Systematic Review on Noninvasive Nonpharmacological Treatment for Chronic Pain: Surveillance Report 3: Literature Update Period: January 2021 through March 2022

This is the third and final update for the 2020 report Noninvasive Nonpharmacological Treatment for Chronic Pain (available at https://effectivehealthcare.ahrq.gov/products/noninvasive-nonpharm-pain-update/research), covering the period January 2021 through March 2022. The 2020 report addressed benefits and harms of noninvasive nonpharmacological therapy for five common chronic pain conditions: low back pain (LBP); neck pain; knee, hip, or hand osteoarthritis (OA); fibromyalgia (FM); and tension headache. Given the clinical and public health importance of this topic, it is important to identify new evidence that could impact practice or policy. The purpose of this surveillance report is to identify new evidence published after December 2021 and to determine how the new evidence impacts findings of the 2020 report and Surveillance Reports 1 and 2, which added evidence from August 2019 through December 2021 and were published on the Agency for Healthcare Research and Quality (AHRQ) website (available at https://effectivehealthcare.ahrq.gov/products/noninvasive-nonpharm-pain-update/research). This is the final surveillance update planned for this topic.